Fagron NV (OTCMKTS:ARSUF – Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 1,868 shares, a growth of 4,948.6% from the May 14th total of 37 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.
Fagron Price Performance
Fagron stock opened at $26.53 on Thursday. The firm has a 50-day moving average price of $26.60 and a two-hundred day moving average price of $25.81. Fagron has a 52-week low of $26.00 and a 52-week high of $27.00.
Fagron Company Profile
Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.
Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.
Further Reading
- Five stocks we like better than Fagron
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Fagron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fagron and related companies with MarketBeat.com's FREE daily email newsletter.
